Open Access

ARTICLE

Overview of transcatheter patent ductus arteriosus closure in preterm infants

Myriam Almeida‐Jones^1,2, Nai Yu Tang^1,2, Aneela Reddy³, Evan Zahn^1,2

1 Guerin Family Congenital Heart Program, Smidt Heart Institute, Los Angeles, California
2 Department of Pediatrics, Cedars‐Sinai Medical Center, Los Angeles, California
3 Department of Pediatrics, University of California Los Angeles, Los Angeles, California

* Corresponding Author: Myriam Almeida‐Jones, MD, Guerin Family Congenital Heart Program, Smidt Heart Institute, 127 S. San Vicente Boulevard, Suite A3100, Los Angeles, CA 90048. Email:

Congenital Heart Disease 2019, 14(1), 60-64. https://doi.org/10.1111/chd.12712

Abstract

Clinically significant patent ductus arteriosus (PDA) has been associated with signifi‐ cant morbidity in extremely low birth weight (ELBW) infants. Current management of ELBW infants with hemodynamically significant PDA includes supportive treatment, pharmacological therapy, and surgical ligation. All of these therapeutic options have their advantages and limitations. More recently, transcatheter PDA closure has been described as a viable option in this population. In this paper, we provide a compre‐ hensive review of this emerging procedure.

---

Keywords

---